| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts
|
|
|
2000
|
9 |
1 |
p. 63-75
13 p.
|
artikel
|
| 2 |
Abstracts
|
|
|
2000
|
9 |
1 |
p. 63-75
|
artikel
|
| 3 |
Age and the Risk of Venous Thromboembolism
|
Frederick A. Anderson, Jr.
|
|
2000
|
9 |
1 |
p. 113-113
1 p.
|
artikel
|
| 4 |
Age and the Risk of Venous Thromboembolism
|
Anderson, Frederick A.
|
|
2000
|
9 |
1 |
p. 113
|
artikel
|
| 5 |
Anticoagulation Clinics and Patient Self-Testing for Patients on Chronic Warfarin Therapy: A Cost-Effectiveness Analysis
|
Jennifer Elston Lafata
|
|
2000
|
9 |
1 |
p. 13-19
7 p.
|
artikel
|
| 6 |
Anticoagulation Clinics and Patient Self-Testing for Patients on Chronic Warfarin Therapy: A Cost-Effectiveness Analysis
|
Lafata, Jennifer Elston
|
|
2000
|
9 |
1 |
p. 13-19
|
artikel
|
| 7 |
Anticoagulation Therapy for Atrial Fibrillation and Coronary Disease
|
Michael D. Ezekowitz
|
|
2000
|
9 |
1 |
p. 47-51
5 p.
|
artikel
|
| 8 |
Anticoagulation Therapy for Atrial Fibrillation and Coronary Disease
|
Ezekowitz, Michael D.
|
|
2000
|
9 |
1 |
p. 47-51
|
artikel
|
| 9 |
Antiphospholipid SyndromeADA
|
Frederick A. Spencer
|
|
2000
|
9 |
1 |
p. 129-130
2 p.
|
artikel
|
| 10 |
Antiphospholipid Syndrome/ADA
|
Spencer, Frederick A.
|
|
2000
|
9 |
1 |
p. 129-130
|
artikel
|
| 11 |
Antiplatelet Drugs in the Elderly
|
David Green
|
|
2000
|
9 |
1 |
p. 115-116
2 p.
|
artikel
|
| 12 |
Antiplatelet Drugs in the Elderly
|
Green, David
|
|
2000
|
9 |
1 |
p. 115-116
|
artikel
|
| 13 |
Biochemical Markers of Platelet Activation
|
Mark L. Furman
|
|
2000
|
9 |
1 |
p. 81-84
4 p.
|
artikel
|
| 14 |
Biochemical Markers of Platelet Activation
|
Furman, Mark L.
|
|
2000
|
9 |
1 |
p. 81-84
|
artikel
|
| 15 |
Bleeding Risk
|
Rebecca J. Beyth
|
|
2000
|
9 |
1 |
p. 121-122
2 p.
|
artikel
|
| 16 |
Bleeding Risk
|
Beyth, Rebecca J.
|
|
2000
|
9 |
1 |
p. 121-122
|
artikel
|
| 17 |
Cardiac Rupture
|
Richard C. Becker
|
|
2000
|
9 |
1 |
p. 77-80
4 p.
|
artikel
|
| 18 |
Cardiac Rupture
|
Becker, Richard C.
|
|
2000
|
9 |
1 |
p. 77-80
|
artikel
|
| 19 |
Community Impact of Anticoagulation Services: Rationale and Design of the Managing Anticoagulation Services Trial (MAST)
|
David B. Matchar
|
|
2000
|
9 |
1 |
p. 7-11
5 p.
|
artikel
|
| 20 |
Community Impact of Anticoagulation Services: Rationale and Design of the Managing Anticoagulation Services Trial (MAST)
|
Matchar, David B.
|
|
2000
|
9 |
1 |
p. 7-11
|
artikel
|
| 21 |
Drug Interactions
|
Philip Hansten
|
|
2000
|
9 |
1 |
p. 123-123
1 p.
|
artikel
|
| 22 |
Drug Interactions
|
Hansten, Philip
|
|
2000
|
9 |
1 |
p. 123
|
artikel
|
| 23 |
Effect of Short-Term Aspirin Use on C-Reactive Protein
|
DaLi Feng
|
|
2000
|
9 |
1 |
p. 37-41
5 p.
|
artikel
|
| 24 |
Effect of Short-Term Aspirin Use on C-Reactive Protein
|
Feng, DaLi
|
|
2000
|
9 |
1 |
p. 37-41
|
artikel
|
| 25 |
Heparin-Induced Thrombocytopenia and its Treatment
|
Theodore E. Warkentin
|
|
2000
|
9 |
1 |
p. 29-35
7 p.
|
artikel
|
| 26 |
Heparin-Induced Thrombocytopenia and its Treatment
|
Warkentin, Theodore E.
|
|
2000
|
9 |
1 |
p. 29-35
|
artikel
|
| 27 |
Homocysteine and Atherothrombotic Vascular Disease
|
Joseph Loscalzo
|
|
2000
|
9 |
1 |
p. 125-126
2 p.
|
artikel
|
| 28 |
Homocysteine and Atherothrombotic Vascular Disease
|
Loscalzo, Joseph
|
|
2000
|
9 |
1 |
p. 125-126
|
artikel
|
| 29 |
Homocysteine and Risk of Cardiovascular Disease
|
Felicita Andreotti
|
|
2000
|
9 |
1 |
p. 13-21
9 p.
|
artikel
|
| 30 |
Homocysteine and Risk of Cardiovascular Disease
|
Andreotti, Felicita
|
|
2000
|
9 |
1 |
p. 13-21
|
artikel
|
| 31 |
Incidence of Factor V Leiden in Patients with Acute Myocardial Infarction
|
Manohar S. Gowda
|
|
2000
|
9 |
1 |
p. 43-45
3 p.
|
artikel
|
| 32 |
Incidence of Factor V Leiden in Patients with Acute Myocardial Infarction
|
Gowda, Manohar S.
|
|
2000
|
9 |
1 |
p. 43-45
|
artikel
|
| 33 |
Inhibition of Platelet Aggregation with a Glycoprotein IIb-IIIa Antagonist Does Not Prevent Thrombin Generation in Patients Undergoing Thrombolysis for Acute Myocardial Infarction
|
Neal S. Kleiman
|
|
2000
|
9 |
1 |
p. 5-12
8 p.
|
artikel
|
| 34 |
Inhibition of Platelet Aggregation with a Glycoprotein IIb-IIIa Antagonist Does Not Prevent Thrombin Generation in Patients Undergoing Thrombolysis for Acute Myocardial Infarction
|
Kleiman, Neal S.
|
|
2000
|
9 |
1 |
p. 5-12
|
artikel
|
| 35 |
INR Self-Management Following Mechanical Heart Valve Replacement
|
Heinrich Koertke
|
|
2000
|
9 |
1 |
p. 41-45
5 p.
|
artikel
|
| 36 |
INR Self-Management Following Mechanical Heart Valve Replacement
|
Koertke, Heinrich
|
|
2000
|
9 |
1 |
p. 41-45
|
artikel
|
| 37 |
Ischemic Preconditioning
|
Karin Przyklenk
|
|
2000
|
9 |
1 |
p. 99-103
5 p.
|
artikel
|
| 38 |
Ischemic Preconditioning
|
Przyklenk, Karin
|
|
2000
|
9 |
1 |
p. 99-103
|
artikel
|
| 39 |
Key References: Anticoagulation Monitoring
|
Richard C. Becker
|
|
2000
|
9 |
1 |
p. 69-76
8 p.
|
artikel
|
| 40 |
Key References: Anticoagulation Monitoring
|
Becker, Richard C.
|
|
2000
|
9 |
1 |
p. 69-76
|
artikel
|
| 41 |
Key References: Basic Fibrinolysis and Thrombolysis Selected References: 19871997
|
Felicita Andreotti
|
|
2000
|
9 |
1 |
p. 61-68
8 p.
|
artikel
|
| 42 |
Key References: Basic Fibrinolysis and Thrombolysis Selected References: 1987–1997
|
Andreotti, Felicita
|
|
2000
|
9 |
1 |
p. 61-68
|
artikel
|
| 43 |
Low Molecular Weight Heparin in the Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism: A Paradigm Change in Care
|
Geno J. Merli
|
|
2000
|
9 |
1 |
p. 21-27
7 p.
|
artikel
|
| 44 |
Low Molecular Weight Heparin in the Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism: A Paradigm Change in Care
|
Merli, Geno J.
|
|
2000
|
9 |
1 |
p. 21-27
|
artikel
|
| 45 |
Medicare Coverage Policies: A Macro and Micro Analysis
|
John J. Whyte
|
|
2000
|
9 |
1 |
p. 37-39
3 p.
|
artikel
|
| 46 |
Medicare Coverage Policies: A Macro and Micro Analysis
|
Whyte, John J.
|
|
2000
|
9 |
1 |
p. 37-39
|
artikel
|
| 47 |
PathologyPhysiology Including Thrombosis
|
Oscar E. Starobin
|
|
2000
|
9 |
1 |
p. 105-106
2 p.
|
artikel
|
| 48 |
Pathology/Physiology Including Thrombosis
|
Starobin, Oscar E.
|
|
2000
|
9 |
1 |
p. 105-106
|
artikel
|
| 49 |
Pharmacokinetics and Pharmacodynamics
|
Ann K Wittkowsky
|
|
2000
|
9 |
1 |
p. 119-119
1 p.
|
artikel
|
| 50 |
Pharmacokinetics and Pharmacodynamics
|
Wittkowsky, Ann K
|
|
2000
|
9 |
1 |
p. 119
|
artikel
|
| 51 |
Preface
|
Jack E. Ansell, M.D.
|
|
2000
|
9 |
1 |
p. 5-5
1 p.
|
artikel
|
| 52 |
Preface
|
Ansell, Jack E.
|
|
2000
|
9 |
1 |
p. 5
|
artikel
|
| 53 |
Prevention of Left Ventricular Remodeling by Percutaneous Transluminal Coronary Angioplasty Performed 24 Hours After the Onset of Acute Myocardial Infarction
|
Ken Kanamasa
|
|
2000
|
9 |
1 |
p. 47-51
5 p.
|
artikel
|
| 54 |
Prevention of Left Ventricular Remodeling by Percutaneous Transluminal Coronary Angioplasty Performed 24 Hours After the Onset of Acute Myocardial Infarction
|
Kanamasa, Ken
|
|
2000
|
9 |
1 |
p. 47-51
|
artikel
|
| 55 |
Protein C, Protein S, and Antithrombin III Deficiencies
|
Frederick A. Spencer
|
|
2000
|
9 |
1 |
p. 127-127
1 p.
|
artikel
|
| 56 |
Protein C, Protein S, and Antithrombin III Deficiencies
|
Spencer, Frederick A.
|
|
2000
|
9 |
1 |
p. 127
|
artikel
|
| 57 |
Reference Guide to Cardiogenic Shock Complicating Acute Myocardial Infarction
|
Venu Menon
|
|
2000
|
9 |
1 |
p. 95-98
4 p.
|
artikel
|
| 58 |
Reference Guide to Cardiogenic Shock Complicating Acute Myocardial Infarction
|
Menon, Venu
|
|
2000
|
9 |
1 |
p. 95-98
|
artikel
|
| 59 |
References on a Wide Variety of Topics Pertaining to Coronary Artery Blood Flow and Patency
|
Mukesh Goel
|
|
2000
|
9 |
1 |
p. 85-93
9 p.
|
artikel
|
| 60 |
References on a Wide Variety of Topics Pertaining to Coronary Artery Blood Flow and Patency
|
Goel, Mukesh
|
|
2000
|
9 |
1 |
p. 85-93
|
artikel
|
| 61 |
Role of ACE Inhibition in Acute Coronary Syndromes
|
Mushabbar Syed
|
|
2000
|
9 |
1 |
p. 107-109
3 p.
|
artikel
|
| 62 |
Role of ACE Inhibition in Acute Coronary Syndromes
|
Syed, Mushabbar
|
|
2000
|
9 |
1 |
p. 107-109
|
artikel
|
| 63 |
Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIbIIIa Receptor Antagonists
|
Sam S. Rebello
|
|
2000
|
9 |
1 |
p. 23-28
6 p.
|
artikel
|
| 64 |
Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor Antagonists
|
Rebello, Sam S.
|
|
2000
|
9 |
1 |
p. 23-28
|
artikel
|
| 65 |
Soluble E-Selectin is Not a Marker of Unstable Coronary Plaque in Serum of Patients with Ischemic Heart Disease
|
Marcello Galvani
|
|
2000
|
9 |
1 |
p. 53-60
8 p.
|
artikel
|
| 66 |
Soluble E-Selectin is Not a Marker of Unstable Coronary Plaque in Serum of Patients with Ischemic Heart Disease
|
Galvani, Marcello
|
|
2000
|
9 |
1 |
p. 53-60
|
artikel
|
| 67 |
Ticlopidine Enhances the Platelet Inhibitory Capacity of Abciximab In Vitro
|
Neal S. Kleiman
|
|
2000
|
9 |
1 |
p. 29-36
8 p.
|
artikel
|
| 68 |
Ticlopidine Enhances the Platelet Inhibitory Capacity of Abciximab In Vitro
|
Kleiman, Neal S.
|
|
2000
|
9 |
1 |
p. 29-36
|
artikel
|
| 69 |
Update in Unfractionated Heparin, Low-Molecular-Weight Heparins, and Heparinoids in the Elderly (Age ≤ 65 years)
|
Sarah A. Spinler
|
|
2000
|
9 |
1 |
p. 117-117
1 p.
|
artikel
|
| 70 |
Update in Unfractionated Heparin, Low-Molecular-Weight Heparins, and Heparinoids in the Elderly (Age ≤ 65 years)
|
Spinler, Sarah A.
|
|
2000
|
9 |
1 |
p. 117
|
artikel
|
| 71 |
Venous Thromboembolism in the Elderly: Introduction and Overview
|
Henry I. Bussey
|
|
2000
|
9 |
1 |
p. 111-112
2 p.
|
artikel
|
| 72 |
Venous Thromboembolism in the Elderly: Introduction and Overview
|
Bussey, Henry I.
|
|
2000
|
9 |
1 |
p. 111-112
|
artikel
|
| 73 |
Workshop: Anticoagulation Disease State Management Utilizing the Internet
|
Terrie A Hellman
|
|
2000
|
9 |
1 |
p. 61-62
2 p.
|
artikel
|
| 74 |
Workshop: Anticoagulation Disease State Management Utilizing the Internet
|
Hellman, Terrie A
|
|
2000
|
9 |
1 |
p. 61-62
|
artikel
|
| 75 |
Workshop: Developing a Business Plan for an Anticoagulation Management Service
|
Jennifer L. Wilson Norton
|
|
2000
|
9 |
1 |
p. 55-56
2 p.
|
artikel
|
| 76 |
Workshop: Developing a Business Plan for an Anticoagulation Management Service
|
Wilson Norton, Jennifer L.
|
|
2000
|
9 |
1 |
p. 55-56
|
artikel
|
| 77 |
Workshop: Implementation of Home Treatment Programs for Deep Vein Thrombosis with Low Molecular Weight Heparin
|
Norman M. Kwong
|
|
2000
|
9 |
1 |
p. 53-54
2 p.
|
artikel
|
| 78 |
Workshop: Implementation of Home Treatment Programs for Deep Vein Thrombosis with Low Molecular Weight Heparin
|
Kwong, Norman M.
|
|
2000
|
9 |
1 |
p. 53-54
|
artikel
|
| 79 |
Workshop: Internet Delivery of an Anticoagulation Therapy Management Certificate Program
|
Nadine Coudret
|
|
2000
|
9 |
1 |
p. 57-59
3 p.
|
artikel
|
| 80 |
Workshop: Internet Delivery of an Anticoagulation Therapy Management Certificate Program
|
Coudret, Nadine
|
|
2000
|
9 |
1 |
p. 57-59
|
artikel
|
Tijdschrift beschrijving